<DOC>
	<DOCNO>NCT01043406</DOCNO>
	<brief_summary>The purpose prospective , single-arm , unblinded , multicenter clinical study evaluate safety effectiveness NeuroVista Seizure Advisory System ( SAS ) patient medically refractory epilepsy . A total 15 subject implant three study site .</brief_summary>
	<brief_title>Seizure Advisory System Feasibility Study</brief_title>
	<detailed_description>This research project aim evaluate effectiveness SAS base well provide subject signal ( `` advisory '' ) see hear predict `` likelihood '' seizure . It monitor signal brain . A secondary purpose study learn whether advisory improve subject quality life caregiver . The SAS make three main component work together monitor subject 's brain signal relay information subject : lead , implantable telemetry unit ( ITU ) , personal advisory device ( PAD ) . The lead place different area subject 's brain record electrical signal . The lead tunnel neck ITU implant chest , similar pacemaker . The ITU wirelessly transmit information PAD , carry like pager . It record process brain signal may able advise subject seizure likely unlikely occur . Following implantation SAS , subject return five study visit neurological examination quality life assessment . Throughout study , subject must maintain SAS ; include daily recharge data card replacement .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>1 . Subject disable partial seizure and/or secondarily generalize partial seizure . Disabling refers seizure severe enough cause injury significantly impair area function employment , psychological social wellbeing , mobility . 2 . Subject fail treatment minimum two AED 's used typical therapeutic dosage . 3 . For three month prior enrollment , subject 's antiepileptic medication dosage stable subject least two disable seizure per month , average , seizurefree interval exceed 45 day . Seizures must separate minimum eight hour consider part cluster . A cluster , purpose criterion , shall consider single seizure . 1 . For three month prior enrollment , subject 's antiepileptic medication dosage stable , subject 12 disabling seizure per month , average , seizurefree interval longer 45 day . Clinical seizure must separate minimum eight hour consider part cluster . A cluster , purpose criterion , shall consider single seizure . 2 . Subject implanted pacemaker , implantable cardiac defibrillator , cardiac management product , medical device interferes SAS SAS interfere . This include , limited , direct brain neurostimulators , spinal cord stimulators , vagus nerve stimulators ( VNS ) , cochlear implant . Patients vagus nerve stimulator implant turned duration study may enrol , provide clinical status stable least one month VNS turn . 3 . Subject diagnose primary generalized seizure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Seizures</keyword>
	<keyword>Advisory</keyword>
	<keyword>Prediction</keyword>
</DOC>